NCT03534687View on ClinicalTrials.gov

Exercise and the Receptor for Advanced Glycation End Products (RAGE)

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

May 8, 2023

Study Completion Date

May 8, 2023

Conditions
Diabetes Mellitus, Type 2
Interventions
BEHAVIORAL

Aerobic Exercise

12-week supervised aerobic exercise

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Michigan

OTHER

NCT03534687 - Exercise and the Receptor for Advanced Glycation End Products (RAGE) | Biotech Hunter | Biotech Hunter